sars-cov-2

Documents about sars-cov-2

• Quantitative Analysis of Protein-Receptor Binding Using Solid-State Nanopores: Accurate Measurement of Dissociation Constants for KREMEN1 and ASGR1 with SARS-CoV‑2 Spike RBD Protein#192989Figshare
• A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic#853599ClinicalTrials.gov
• Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome#868610ClinicalTrials.gov
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients#830009ClinicalTrials.gov
• Artificial Intelligence (AI) and Big Data for Coronavirus (COVID-19) Pandemic: A Survey on the State-of-the-Arts#686373OpenAlex
• Implications of COVID-19 Restrictions on the Ethics and Methods of a Multi-Site Study on Alcohol and Other Drug (AOD) Use Treatment among Men in South Africa.#281579PubMed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants#300317ClinicalTrials.gov
• Determinación de los niveles de anticuerpos IgG ANTI S-RBD SARS-CoV-2 en individuos que han recibido la segunda dosis de las vacunas BNT162b2 O CoronaVac de la región del BioBío, Chile.#462225Repositorio
• Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.#854954ClinicalTrials.gov
• An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older#121428ClinicalTrials.gov
• Prospective Evaluation of COVID-19 Vaccine in Transplant Recipients: A National Strategy [PREVenT-COVID, study data contributed to the CITF Databank]#411198Borealis Dataverse OAI Archive
• Pseudo partial likelihood method for proportional hazards models when time origin is missing for control group with applications to SARS-CoV-2 seroprevalence study#416657University of Pretoria Repository
• Machine learning-driven near- and mid-infrared chemometrics for rapid, cost-effective COVID-19 screening in dried plasma#680226Repositório Institucional da UFMG
• Multi-Center Registry for ME/CFS#828848ClinicalTrials.gov
• Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)#833926ClinicalTrials.gov
• Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients#860216ClinicalTrials.gov
• Développement d’un modèle in vitro pour évaluer l’efficacité de prévention et de traitement des manifestations cutanées provoquées par l’application des mesures d’hygiène dans le contexte de la COVID-19#124540HAL (France)
• Experimental infection of alpacas (Vicugna pacos) with influenza C or D viruses results in subclinical upper respiratory tract disease#350749HAL (France)
• Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics#867355ClinicalTrials.gov
• Associations between Emotional Distress, Sleep Changes, Decreased Tooth Brushing Frequency, Self-Reported Oral Ulcers and SARS-Cov-2 Infection during the First Wave of the COVID-19 Pandemic: A Global Survey#355815University of Ibadan Institutional Repository
• Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda#405205ClinicalTrials.gov
• SARS-CoV-2 pseudoparticles preferentially infect ectoderm in human embryonic tissues#620103eScholarship
• An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19#855803ClinicalTrials.gov
• Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)#857804ClinicalTrials.gov
• Rôle des Espèces Réactives de l’Oxygène (ROS) : du stress nucléolaire induit par EBNA-1 au contrôle de l'inflammation par la lumière proche infrarouge sur modèles infectieux et métaboliques#142479HAL (France)
• Denaturing and dNTPs reagents improve SARS-CoV-2 detection via single and multiplex RT-qPCR#153663HAL (France)
• Table 3_Assessing the prevalence of anosmia and taste dysfunction in COVID-19 patients in Saudi Arabia: a systematic review and meta-analysis.xlsx#384358Figshare
• Image 1_Assessing the prevalence of anosmia and taste dysfunction in COVID-19 patients in Saudi Arabia: a systematic review and meta-analysis.png#384359Figshare
• Table 5_Assessing the prevalence of anosmia and taste dysfunction in COVID-19 patients in Saudi Arabia: a systematic review and meta-analysis.xlsx#384360Figshare
• Table 1_Assessing the prevalence of anosmia and taste dysfunction in COVID-19 patients in Saudi Arabia: a systematic review and meta-analysis.xlsx#384361Figshare
• Table 4_Assessing the prevalence of anosmia and taste dysfunction in COVID-19 patients in Saudi Arabia: a systematic review and meta-analysis.xlsx#384362Figshare
• Invasive Aspergillosis Complicating Severe COVID-19: Cumulative Incidence, Risk Factors, and Outcomes Between the First Wave of the Pandemic and Subsequent Waves, According to the ECMM/ISHAM Classification and a Local Case Assessment#652703HAL (France)
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)#828626ClinicalTrials.gov
• Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome#835682ClinicalTrials.gov
• The Effect of the 2020 COVID-19 Pandemic Lockdown on Hand Injury Patient Numbers and Profiles at Charlotte Maxeke Johannesburg Academic Hospital: A Retrospective Study from 2019 to 2021#451032WIReDSpace
• Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses#876921ClinicalTrials.gov
• SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area#676015eScholarship
• In silico analysis of C₆₀ fullerene interaction with TMPRSS2: toward novel COVID-19 prevention approaches#463859Dbt
• B Cell Receptor’s function in virus entry: Anti-SARS-CoV-2 B cell receptors can mediate viral entry in an ACE2-independent mechanism#609439eScholarship
• Data used in publication: Rakib Das et al. - Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir#207971Yoda MOAI Feed
• A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy#827172ClinicalTrials.gov
• Coronavirus Disease 2019 is an Occupational Disease for Teachers: How to Support the Teacher Workforce.#683961eScholarship
• A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir#879497ClinicalTrials.gov
• Expresión y caracterización del complejo proteico de la ARN polimerasa de SARS-CoV-2#477272Repositorio Institucional BUAP
• Procurement of laboratory Equipment, Reagent, and Supplies (4 BD MAX system; 4 BD SARS-CoV-2 Reagents; D MAX™ Enteric Viral Panel, PCR Cartridge and others as outlined in ths schedule) — Sierra Leone - Quality Essential Health Services an#606992World Bank
• Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)#832421ClinicalTrials.gov
• “El impacto de la pandemia de la COVID-19 sobre el diagnóstico de la tuberculosis en el Perú desde la perspectiva de los pacientes: un estudio de métodos mixtos”#255963Repositorio Universidad Peruana Cayetano Heredia
• Evidencias de la posición prona sobre la mecánica ventilatoria de pacientes con Síndrome de Distrés Respiratorio Agudo ocasionado por SARS COV - 2 en la unidad de cuidados intensivos#292941Repositorio Universidad Peruana Cayetano Heredia
• Atención y motivos de descompensación de patologías no relacionadas con la infección por el virus del SARS-CoV-2 en el contexto de pandemia COVID-19 en el Hospital Centro Médico Naval. Julio 2020 – junio 2021#348706Repositorio Universidad Peruana Cayetano Heredia
• Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19: orientaciones provisionales, 9 de marzo de 2022: anexo B de la web: autodiagnóstico de la COVID-19 mediante el uso de pruebas de diagnóstico rápido de detección de antígenos: evaluación de la viabilidad entre el personal de salud y la población general en Malawi y Zimbabwe#422116WHO IRIS